Markets:

Overview

News

Currencies

International

Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

5.275 +0.075 (+1.44%)

Streaming Delayed Price Updated: 2:13 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

30 31 Next >

Psychedelic Stock Gainers And Losers From May 26, 2022 ↗

May 26, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.06% at $0.34

Via Benzinga

TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

May 25, 2022

GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 6.06% at $23.45

Via Benzinga

Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company ↗

May 24, 2022

Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.

Via Benzinga

Psychedelic Stock Gainers And Losers From May 24, 2022 ↗

May 24, 2022

GAINERS: LOSERS: Cybin (AMEX:CYBN) shares closed down 9.99% at $0.61

Via Benzinga

Compass Pathways: Q1 Earnings Insights ↗

May 10, 2022

Compass Pathways (NASDAQ:CMPS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Cybin, Small Pharma Among Top Psychedelic Movers Of Today ↗

May 23, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68

Via Benzinga

Christian Angermayer Bullish On Psychedelic Sector And Life Extension Technology ↗

May 23, 2022

In this week’s Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer.

Via Benzinga

Can Psilocybin Help With Treatment-Resistant Depression? COMPASS Pathways Study Shows Promising Results ↗

May 23, 2022

COMPASS Pathways plc (NASDAQ: CMPS), a mental health care company, presented positive data from the randomized, controlled, double-blind study of psilocybin therapy, at the American Psychiatric...

Via Benzinga

Psychedelic Stock Gainers And Losers From May 20, 2022 ↗

May 20, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 8.33% at $0.77

Via Benzinga

Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say ↗

May 20, 2022

Patents are the golden eggs of the booming psychedelic space.

Via Benzinga

Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗

May 19, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.90% at $0.29

Via Benzinga

Cybin, Allied Among Top Psychedelic Movers Of Today ↗

May 18, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 13.43% at $0.55

Via Benzinga

Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗

May 17, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.85% at $0.32

Via Benzinga

Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies ↗

May 17, 2022

The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022.

Via Benzinga

Psychedelic Stock Gainers And Losers From May 16, 2022 ↗

May 16, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 25.00% at $0.22

Via Benzinga

Psychedelic Compounds-Based Stocks Index Imploding ↗

May 14, 2022

Our index of Psychedelic Compounds-Based Drug Stocks tracks clinical-stage startups still in R&D is down 60% YTD; -78% from its 2021 high.

Via Talk Markets

Field Trip Health, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

May 13, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 20.93% at $0.94

Via Benzinga

Psychedelic Stock Gainers And Losers From May 12, 2022 ↗

May 12, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $7.06

Via Benzinga

Compass Pathways Research Suggests Psilocybin Can Treat Anorexia

May 12, 2022

Via Investor Brand Network

Psychedelic Stock Gainers And Losers From May 11, 2022 ↗

May 11, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 1.37% at $0.27 LOSERS:

Via Benzinga

Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021 ↗

May 11, 2022

Compass Pathways (NASDAQ: CMPS) announced its financial results for the first quarter of 2022, which ended March 31. Q1 Results For the first three months of the year, net loss was $21.2 million, or...

Via Benzinga

Intelgenx Technologies, Compass Pathways Among Top Psychedelic Movers Of Today ↗

May 10, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.68% at $0.26

Via Benzinga

Psyched: Protesters At DEA HQ Demand Access To Psychedelics, Connecticut Approves Budget Bill With MDMA & Psilocybin Programs ↗

May 10, 2022

Psychedelics policy action took center stage this week.

Via Benzinga

EXCLUSIVE: Kevin Harrington Becomes The Latest 'Shark Tank' Judge To Enter The Psychedelics Space ↗

May 10, 2022

The psychedelics industry is quickly becoming the latest playground for celebrity investors and influencers in the financial sphere. Kevin Harrington, one of the original “sharks” in ABC's “Shark Tank”...

Via Benzinga

Psychedelic Stock Gainers And Losers From May 9, 2022 ↗

May 09, 2022

GAINERS: LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 13.47% at $3.34

Via Benzinga

A Preview Of Compass Pathways's Earnings ↗

May 09, 2022

Compass Pathways (NASDAQ:CMPS) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Compass...

Via Benzinga

New Study To Evaluate Magic Mushroom's Therapeutic Potential On Autistic Adults ↗

May 09, 2022

Psychedelics continue to garner attention as possible treatments for diverse mental health conditions. Now, Compass Pathways (NASDAQ: CMPS) will undertake a study to evaluate psilocybin’s effects on...

Via Benzinga

Psychedelic Stocks Continue To Decline In May ↗

May 08, 2022

The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue.

Via Talk Markets

TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today ↗

May 06, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16

Via Benzinga

GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗

May 05, 2022

GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS:

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.